Haleon plc — Form 6-K Summary
Business context and reporting period
Haleon plc filed this Form 6-K for July 2022 on July 20, 2022. The filing contains three EU Market Abuse Regulation notifications reporting share and American Depositary Share (ADS) allocations to persons discharging managerial responsibilities (PDMRs) following Haleon’s demerger from GSK. It is not an earnings or periodic financial report.
Financial metrics and liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, balance-sheet data, or financial guidance. It also does not provide a purchase price or market value for the securities; each reported transaction price is listed as “n/a.”
Material changes versus the prior comparable period
No comparable-period financial information is presented. The material event disclosed is the receipt of Haleon ordinary shares or ADSs by PDMRs under the terms of the GSK demerger and the prospectus dated June 1, 2022.
| Reported recipient | Position | Instrument | Quantity | Transaction date |
|---|---|---|---|---|
| Tobias Hestler | Chief Financial Officer | Ordinary shares | 10,464 | July 18, 2022 |
| Keith Choy | President, Asia Pacific | Ordinary shares | 17,864 | July 18, 2022 |
| Bart Derde | Chief Supply Chain Officer | Ordinary shares | 21,278 | July 18, 2022 |
| Amy Landucci | Chief Digital and Technology Officer | Ordinary shares | 17,994 | July 18, 2022 |
| Filippo Lanzi | President, EMEA & LATAM | Ordinary shares | 44,376 | July 18, 2022 |
| Franck Riot | Chief R&D Officer | Ordinary shares | 1,376 | July 18, 2022 |
| Tamara Rogers | Chief Marketing Officer | Ordinary shares | 104 | July 18, 2022 |
| Brian McNamara | Chief Executive Officer | ADSs | 121,929 | July 18, 2022 |
| Amy Landucci | Chief Digital and Technology Officer | ADSs | 5,681 | July 18, 2022 |
| Teri Lyng | Head of Transformation and Sustainability | ADSs | 19,049 | July 18, 2022 |
| Lisa Paley | President, North America | ADSs | 7,126 | July 18, 2022 |
| Vindi Banga | Senior Independent Director | Ordinary shares | 71,800 | July 19, 2022 |
Based on the quantities disclosed, the notifications cover 185,256 ordinary shares and 153,785 ADSs. The filing describes these as shares or ADSs received in connection with the demerger, rather than open-market purchases or sales.
Guidance, outlook, risks, contingencies, and unusual items
- No management outlook, earnings guidance, risk update, contingency, or unusual operating item is disclosed.
- The ordinary shares are described as having a nominal value of £1.25 each, subject to reduction to 1 pence following the company’s capital reduction. Investors should refer to the prospectus for the detailed mechanics.
- The ordinary-share transactions were reported on the London Stock Exchange; the ADS transactions were reported on the New York Stock Exchange.
Most important facts for investors to verify
- Confirm the demerger-related allocation terms in Haleon’s June 1, 2022 prospectus.
- Verify the planned reduction in ordinary-share nominal value from £1.25 to 1 pence and its effect on the share capital structure.
- Confirm that the reported transactions were distributions or receipts under the demerger and not acquisitions at a stated market price.
- Review subsequent filings for any sales, lock-up expirations, or changes in PDMR holdings.
- Use a separate earnings filing or annual report to assess Haleon’s revenue, profitability, cash flow, leverage, and liquidity, because this Form 6-K does not provide those metrics.